A Global Active Surveillance for Community Acquired Pneumonia

Pfizer

Status: Completed

Conditions: Community Acquired Pneumonia

Treatments: Procedure: Nasopharyngeal swab; Procedure: urine specimen; Procedure: Blood draw; Procedure: Chest X-ray; Procedure: sputum

Study type: Interventional

Funder types: Industry

Identifiers

NCT00929721

6115A1-4000

Details and patient eligibility

About

This study is an observational surveillance study to identify adults 50 years and older who present to a study healthcare facility with signs and symptoms of Community-Acquired Pneumonia.

Enrollment: 5,172 patients

Sex: All

Ages: 50+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult subjects 50 years of age or older
• Subject must reside in the surveillance area
• Subjects who present to a study healthcare facility where the treating physician clinically suspects CAP

Exclusion criteria

• Any subject who is transferred to a study healthcare facility after already being hospitalized for 48 hours or more at any other in-patient facility (such as a community hospital).
• Hospital Acquired pneumonia (ie, develops signs and symptoms of pneumonia after being hospitalized for 48 hours or more).

Trial design

5,172 participants in 1 patient group

Subjects with Community-Acquired Pneumonia

Other group

Description:

Subjects with Community-Acquired Pneumonia

Treatment:

Procedure: sputum

Procedure: Chest X-ray

Procedure: Blood draw

Procedure: urine specimen

Procedure: Nasopharyngeal swab